Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/31661| Title: | The (re)challenging question of erythropoiesis-stimulating agents inducing pure red cell aplasia. | Authors: | Summers S.;Holdsworth S. ;Sharples E. | Institution: | (Summers, Holdsworth) Department of Medicine, Monash Medical Centre, Monash University, Clayton, VIC, Australia (Sharples) Churchill Hospital, Oxford Renal Unit, Oxford, United Kingdom (Summers) Centre for Inflammatory Diseases, Monash Medical Centre, Monash University, Clayton, VIC, Australia | Issue Date: | 17-Oct-2012 | Copyright year: | 2008 | Publisher: | Oxford University Press (Great Clarendon Street, Oxford OX2 6DP, United Kingdom) | Place of publication: | United Kingdom | Publication information: | Nephrology Dialysis Transplantation. 23 (10) (pp 3053-3055), 2008. Date of Publication: October 2008. | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1093/ndt/gfn326 | PubMed URL: | 18558625 [http://www.ncbi.nlm.nih.gov/pubmed/?term=18558625] | ISSN: | 0931-0509 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/31661 | Type: | Editorial | Subjects: | priority journal *pure red cell anemia/dt [Drug Therapy] *pure red cell anemia/si [Side Effect] *pure red cell anemia/th [Therapy] pure red cell anemia/si [Side Effect] treatment response calcineurin inhibitor/cm [Drug Comparison] calcineurin inhibitor/dt [Drug Therapy] continuous erythropoiesis receptor activator/dt [Drug Therapy] corticosteroid derivative/dt [Drug Therapy] cyclophosphamide/cb [Drug Combination] cyclophosphamide/dt [Drug Therapy] cyclosporin/cb [Drug Combination] cyclosporin/dt [Drug Therapy] erythropoietin/ec [Endogenous Compound] immunoglobulin/cm [Drug Comparison] immunoglobulin/dt [Drug Therapy] immunoglobulin/iv [Intravenous Drug Administration] novel erythropoiesis stimulating protein/dt [Drug Therapy] *recombinant erythropoietin/ae [Adverse Drug Reaction] *recombinant erythropoietin/dt [Drug Therapy] *recombinant erythropoietin/iv [Intravenous Drug Administration] *recombinant erythropoietin/sc [Subcutaneous Drug Administration] rituximab/dt [Drug Therapy] steroid/cb [Drug Combination] unclassified drug erypro steroid/dt [Drug Therapy] anemia/dt [Drug Therapy] *chronic kidney disease disease association drug withdrawal editorial erythrocyte transfusion graft versus host reaction/dt [Drug Therapy] graft versus host reaction/pc [Prevention] human immune response immunosuppressive treatment nonhuman plasmapheresis immunosuppressive treatment nonhuman plasmapheresis priority journal *pure red cell anemia / *drug therapy / *side effect / *therapy pure red cell anemia / side effect anemia / drug therapy treatment response *chronic kidney disease disease association drug withdrawal editorial erythrocyte transfusion graft versus host reaction / drug therapy / prevention human immune response |
Type of Clinical Study or Trial: | Opinion, perspective or news |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.